Gautam V. Ramani, MD

• BS, Pennsylvania State University, University Park State College, PA
• MD, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA
• Resident, Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA
• Chief Medical Resident, University of Pittsburgh Medical Center, Pittsburgh, PA
• Fellow, Cardiovascular Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA
• Fellow, Congestive Heart Failure/Transplantation/Pulmonary Hypertension, University of Pittsburgh Medical Center, Pittsburgh, PA

Dr. Ramani’s clinical and research interests are focused on patients with advanced heart and pulmonary vascular disease, particularly those with late stage heart failure or pulmonary vascular disease who require heart transplantation or mechanical circulatory support. Dr. Ramani is the site PI for several multicenter clinical trials, investigating pharmacotherapy for pulmonary arterial hypertension, as well as risk assessment and treatment options in different types of pulmonary hypertension. He also is the primary investigator investigating pharmacogenomics in hydralazine/nitrate therapy in systolic heart failure.

1. Baker S, Ramani GV. Heart failure in the elderly.  Clinical Geriatrics.  December 2011. 21-27.

2. Ramani GV, Kligerman S, Lehr E.  Multimodality imaging of a thrombus in transit crossing a patent forman ovale.  J Am Coll Cardiol 2012;59(6):e19

3. Reed RM, Ramani GV, Hashmi S.  Unraveling the paradox of cardiac tamponade: case presentation and discussion of physiology. BMJ Case Reports 2012;10.1136/bcr.09.2011.4792

4. Ramani GV.  Inhaled prostacyclin therapy for pulmonary arterial hypertension – a promise unfulfilled? Expert Opin Pharmacother 2012;13(7):923-925

5. Ramani GV, Park MH.  Pharmacotherapy for pulmonary arterial hypertension.  Heart Fail Clin 2012;8(3): 385-402

    

6. Klein T, Ramani GV.  Assessment and management of cardiogenic shock in the emergency department.  Cardiol Clin 2012;30(4): 651-664

7. Ramani GV, Gill SS.  Pharmacologic Treatment of Pulmonary arterial Hypertension.  Curr Pharm Des 2012; PMID 23228314

8. Timofte I, Potosky D, Ramani GV, Reed RM. Diaphragmatic herniation due to massive hepatomegaly in a patient with pulmonary arterial hypertension.  BMJ Case Rep 2015 Jun 10;2015

9. Ramani GV, Kligerman SJ, Reed RM.  A bad shortcut:  Partial anomalous pulmonary venous return.  BMJ Case Rep 2014;

10. McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, Modi K, Alexis JD, Ramani GV, Semingram MJ, Fett JD.  Clinical outcomes for peripartum cardiomyopathy in North America: Results of the IPAC Study.  J Am Coll Cardiol 2015;66(8): 905-914

11. Sheppard R, Hsich E, Damp J, Elkayam U, Kealey A, Ramani G, Zucker M, Alexis JD, Horne BD, Hanley-Yanez K, Pisarcik J, Halder I, Fett JD, Mcnamara DM; IPAC Investigators. GNB3 C825T Polymorphism and Myocardial Recovery in Peripartum Cardiomyopathy.  Results of the Multicenter Investigation of Pregnancy Associated  Cardiomyopathy  Study. Circ Heart Fail 2016 Mar;9(3);e002683

12. Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, Tsai EJ, Hilfiker-Kleiner D, Kamiya CA, Mazzarotto F, Cook SA, Halder I, Prasad SK, Pisarcik J, Hanley-Yanez K, Alharethi R, Damp J, Hsich E, Elkayam U, Sheppard R, Kealey A, Alexis J, Ramani G, Safirstein J, Boehmer J, Pauly DF, Wittstein IS, Thohan V, Zucker MJ, Liu P, Gorcsan J 3rd, McNamara DM, Seidman CE, Seidman JG, Arany Z; IMAC-2 and IPAC Investigators. N Engl J Med 2016 Jan 21;374(3): 233-241